Prevalence of human immunodeficiency virus infection in patients with pulmonary tuberculosis at the National Chest Hospital in Jamaica

Revista Panamericana de Salud Publica/Pan American Journal of Public Health

Volumn 19, Issue 1, 2006, Pages 38-43

  Akpaka, Patrick E ^a,c   Tulloch Reid, Mikael ^b   Justiz Vaillant, Angel ^a   Smikle, Monica F ^a  

^a UNIVERSITY OF THE WEST INDIES   (Jamaica)

^b National Chest Hospital   (Jamaica)

^c Faculty of Medical Sciences   (Trinidad and Tobago)

Author keywords

HIV; Hospital; Jamaica; Mortality; Prevalence; Symptoms; Tuberculosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

DISEASE PREVALENCE; DISEASE SEVERITY; DRUG RESISTANCE; HOSPITAL SECTOR; HUMAN IMMUNODEFICIENCY VIRUS; MORTALITY; TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; CHILD; CLINICAL FEATURE; DEMOGRAPHY; FEMALE; HOSPITAL; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; JAMAICA; LABORATORY DIAGNOSIS; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; RETROSPECTIVE STUDY; REVIEW; SOCIAL STATUS; SYMPTOMATOLOGY; TREATMENT OUTCOME; AGE; ARTICLE; COMORBIDITY; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DRUG EFFECT; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; PRESCHOOL CHILD; SERODIAGNOSIS; SEX DIFFERENCE; SPUTUM; STATISTICAL ANALYSIS;

ATLANTIC ISLANDS; ATLANTIC OCEAN; CARIBBEAN ISLANDS; GREATER ANTILLES; JAMAICA;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MYCOBACTERIUM TUBERCULOSIS;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTITUBERCULAR AGENTS; CHILD; CHILD, PRESCHOOL; COMORBIDITY; CROSS-SECTIONAL STUDIES; DATA INTERPRETATION, STATISTICAL; FEMALE; HIV INFECTIONS; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HIV-1; HOSPITALS, SPECIAL; HUMANS; JAMAICA; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; RETROSPECTIVE STUDIES; SEX FACTORS; SPUTUM; TUBERCULOSIS, PULMONARY;

EID: 33645577616     PISSN: 10204989     EISSN: 16805348     Source Type: Journal    
DOI: 10.1590/S1020-49892006000100006     Document Type: Review

References (27)

1. Friedman LN, Williams MT, Sing TP, Frieden TR. Tuberculosis, AIDS, and death among substance abusers on welfare in New York City. N Engl J Med. 1996;334:828-33.
2. Gordin FM, Matts JP, Miller C, Brown LS, Hafner R, John SL, et al. A controlled trial of isoniazid in persons with anergy and HIV infection who are at high risk for pulmonary tuberculosis. N Engl J Med. 1997;337:315-20.
3. Small PM, Hopewell PC, Singh SP, Paz A, Parsonnet J, Ruston DC, et al. The epidemiology of tuberculosis in San Francisco - a population-based study using conventional and molecular methods. N Engl J Med. 1994;330:1703-9.
4. Centers for Disease Control and Prevention. Management of persons exposed to multidrug-resistant tuberculosis. MMWR Morb Mortal Weekly Rep. 1992;41(RR-II):61-71.
5. Godfrey-Faussett P, Maher D, Mukadi YD, Nunn P, Perriëns J, Raviglione M. How immunodeficiency virus voluntary testing can contribute to tuberculosis control. Bull World Health Organ. 2002;80(12):939-45.
6. Lucas SB, Hounnou A, Peacock CS, Beaumel A, Djomand G, N'Gbichi J-M, et al. The mortality and pathology of HIV disease in a west African city. AIDS. 1993;7:1569-79.
7. Raviglione MC, Harries AD, Msiska R, Wilkinson D, Nunn P. Tuberculosis and HIV: current status in Africa. AIDS. 1997; 11(Suppl B):S115-23.
8. Maher D, Floyd K, Raviglione M. Strategic framework to decrease the burden of pulmonary tuberculosis/HIV. Geneva: WHO; 2002. (WHO document WHO/CDS/Pulmonary Tuberculosis/2002.296).
9. UNAIDS/WHO AIDS epidemic update: December 2004. [Internet site]. Available from: http://www.unaids.org/wad2004/EPI_1204_pdf_en/ chapter4_caribbean_en.pdf Accessed 28 October 2005.
10. Metchock BG, Nolte FS, Wallace Jr RJ. Mycobacterium. In: Murray PE, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of Clinical Microbiology (7th ed.), Washington, D.C.: ASM Press; 1999. Pp. 399-437.
11. Whalen CC, Johnson JL, Okwera A, Hom DL, Huebner R, Mugyenyi P, et al. for The Uganda-Case Western Reserve University Research Collaboration. A trial of three regimens to prevent tuberculosis in Ugandan adults infected with human immunodeficiency virus. N Engl J Med. 1997;337:801-8.
12. International Union Against Tuberculosis and Lung Disease. Technical guide for sputum examination for tuberculosis by direct microscopy. Bull Int Union Against Tuberc Lung Dis. 1986;61:1-16.
13. Joint United Nations Programme on HIV/AIDS, World Health Organization. UNAIDS/WHO Policy Statement on HIV testing. Geneva: WHO; June 2004.
14. Chien-Ching Hung, Mao-Yuan Chen, Chin-Fu Hsiao, Szu-Min Hsieh, Wang-Huei Sheng, Shan-Chwen Chang. Improved outcomes of HIV-1-infected adults with tuberculosis in the era of highly active antiretroviral therapy. AIDS. 2003;17:2615-22.
15. Onorato IM, McCray E. Prevalence of human immunodeficiency virus infection among patients attending tuberculosis clinics in the United States. J Infect Dis. 1992;165:87-92.
16. Eriki PP, Okwera A, Aisu T, Morrisey AB, Ellner JJ, Daniel TM. The influence of human immunodeficiency virus infection on tuberculosis in Kampala, Uganda. Am Rev Respir Dis. 1991;143:185-7.
17. Jain SK, Aggarwal JK, Rajpal S, Baveja U. Prevalence of HIV infection among tuberculosis patients in Delhi-A sentinel surveillance study. Ind J Tuberc. 2000;47:21-6.
18. Roussel HM, Rastogi TN. Evolution de la tuberculose en Guadeloupe entre 1982 et 1994. Bull Epidemiol Hebd. 2/1996:5-6.
19. Sola C, Horgen L, Goh KS, Rastogi N. Molecular fingerprinting of Mycobacterium tuberculosis on a Caribbean Island with IS6110 and DRr Probes. J Clin Microbiol. 1997;35:843-6.
20. World Health Organization. Tuberculosis. Annexes. Annex 1: Profiles of High burden countries. [Internet site]. Available from: http://www.who.int/tb/ publications/global_report/2005/annex_download_centre/en/index.html Accessed 4 November 2005.
21. World Health Organization. TB epidemiological profile as of 31 May 2005. Global Health Atlas. [Internet site]. Available from: http://www.who.int/ GlobalAtlas/predefined Reports/TB/PDF_Files/country_2003_briefpdf Accessed 4 November 2005.
22. Bruchfeld J, Aderaye G, Palme IG, Bjorvatn B, Ghebremichael S, Hoffner S, et al. Molecular epidemiology and drug resistance of Mycobacterium tuberculosis isolates from Ethiopian pulmonary tuberculosis patients with and without HIV infection. J Clin Microbiol. 2002;40:1636-43.
23. Holmes CB, Hausler H, Nunn P. A review of sex differences in the epidemiology of tuberculosis. Int J Tuberc Lung Dis. 1998;2:96-104.
24. Havlir DV, Barnes PF. Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med. 1999;340:367-73.
25. Garin B, Glaziou P, Kassa-Kelembho E, Yassibanda S, Mbelesso P, Morvan J. High mortality rates among patients with tuberculosis in Bangui, Central African Republic. Lancet. 1997;350:1298.
26. Hopewell PC. Tuberculosis in persons with human immunodeficiency virus infection: clinical and public health aspects. Semin Respir Crit Care Med. 1997;18:471-84.
27. World Health Organization, International Union Against Tuberculosis and Lung Disease, Royal Netherlands Tuberculosis Association. Revised international definitions in tuberculosis control. Int J Tuberc Lung Dis. 2001;5:213-5.